Since joining Kirkland, Melvin has worked on the following matters, advising:
- Maesa on the sale of European and Middle Eastern operations
Prior to joining Kirkland, Melvin worked on the following matters, advising:
- Ateliers de France on the €260 million financing of the acquisition of the group by the founders, management, Bpifrance and other investors;
- Elyan Partners on the refinancing of its acquisition and the delisting of Oncodesign services;
- Five Arrows on the €505 million unitranche financing of its reinvestment in A2MAC1 alongside Providence Equity Partners;
- Iliad:
- on the raising of a €5 billion financing from a pool of 23 leading international banks;
- on the raising of a €300 million term loan financing from European Investment Bank;
- HLD on the €120 million financing of its acquisition of Ba&sh from its founders;
- Ubisoft on the refinancing of its financial indebtedness with the proceeds of a new €325 million term loan facility and €300 million revolving credit facility;
- Compagnie Lebon on the refinancing of its financial indebtedness with the proceeds of a new €20 million amortizing loan facility and a €70 million revolving credit facility;
- DBay Advisors on the €90 million unitranche financing of its tender offer for SQLI;
- Comexposium on certain financing matters in connection with the debt restructuring of the Comexposium group;
- Silver Lake and Cegid on the refinancing of Cegid’s financial indebtedness and the acquisition of Talentsoft with the proceeds of a new €880 million term loan B facility and €75 million revolving credit facility;
- Ineos on various high-yield and loan financings;
- Hayfin on its €120 million unitranche financing for the acquisition by TowerBrook Capital Partners L.P. of Consolis Rail;
- Elsan on the €350 million financing of its acquisition of Groupe C2S from Eurazeo;
- Terreal on the €90 million financing of its acquisition of Creaton from Etex;
- Novalpina Capital on the €162.5 million unitranche financing of its acquisition of Laboratoire X.O. from its founders;
- 3i and Evernex on the amendment and extension of Evernex’s senior facilities;
- 3i and Havea Group on the amendment and extension of Havea’s senior facilities;
- Orapi on certain financing matters in connection with the debt restructuring of the Orapi group;
- Kiloutou on the raising of a €150 million incremental facility; and
- Ceva Santé Animale on the refinancing of its senior indebtedness with the proceeds of a new €2 billion term loan B facility and €150 million revolving credit facility.
